Free Preview
In this week’s podcast, 7investing lead advisor Luke Hallard catches up with health tech expert investor Adu Subramanian to chat about Semler Scientific (NASDAQ: SMLR) -- an exciting $300M healthcare technology business that’s rapidly becoming the standard of care for diagnosing peripheral arterial disease (PAD).